New heart ablation waveforms aim to tame atrial fibrillation
NCT ID NCT07444320
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times
Summary
This study tests new waveforms delivered by the FARAPULSE PFA system to treat atrial fibrillation, a common heart rhythm problem. About 200 adults with paroxysmal or persistent atrial fibrillation will receive the procedure. The goal is to see if these new waveforms are safe and can effectively isolate the pulmonary veins and posterior wall of the heart to restore normal rhythm.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FARAPULSE Pulsed Field Ablation (PFA) System (device)
What this could lead to
If successful, this could offer a safer, more precise way to treat atrial fibrillation, potentially reducing complications and improving outcomes.
What could go wrong
This is an early feasibility study with only 200 participants, so results may not apply to everyone. There are risks of procedure-related complications like bleeding or heart rhythm issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAROXYSMAL ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Klinicki Bolnicki Centar Split
RECRUITINGSplit, 21 000, Croatia
Contact
Contact Email: •••••@•••••
-
Na Homolce Hospital
RECRUITINGPrague, 15030, Czechia
Contact Email: •••••@•••••
Contact
-
Queen Mary Hospital
NOT_YET_RECRUITINGHong Kong, Hong Kong
Contact Email: •••••@•••••
Contact
-
Taipei Veterans General Hospital-Hospital
NOT_YET_RECRUITINGTaipei, 1127, Taiwan
Contact